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Purpose: Calcium stones represent 85% to 90% of all urinary calculi, including various 
crystalline compositions and etiological conditions. Calcium phosphate accounts for 10% to 
15% of cases. These stones are mainly related to 3 groups of risk factors, including calcium or 
phosphate metabolism disturbance, renal acidification defects and urinary tract infection. 
Identifying the stone etiology often requires extensive metabolic evaluation. We assessed 
whether stone analysis including morphological typing in addition to stone composition could 
be a valuable help for diagnosis. 
Materials and Methods: Of 60,564 stones analysed by morphological examination and 
infrared spectroscopy at our laboratory 6,439 (10.6%) were mainly composed of carbapatite. 
Of these stone 1,093 patients were included in study who had an available etiological 
diagnosis and stones containing at least 70% of calcium phosphate without struvite. 
Results: Of the 1,093 calcium phosphate stones 12.8% showed a peculiar morphology termed 
IVa2, characterized by a smooth aspect and a glazed brown yellow appearance with tiny 
cracks. This was associated with inherited distal renal tubular acidosis in 96.1% of cases. In 
contrast, the other stones of similar composition but different morphology were related to 
distal renal tubular acidosis in only 3.9% of cases. In addition, IVa2 stones were found in 65% 
of calcium phosphate stone formers associated with Sjögren syndrome and in 35% of calcium 
phosphate stones in patients with medullary sponge kidney. These 2 conditions are related to a 
mild to moderate distal acidification defect. 
Conclusions: Identifying IVa2 stone morphology is clinically relevant because it should 
prompt clinicians to search for complete or incomplete distal acidosis and initiate specific 
therapy to decrease recurrence. 
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Introduction 
 
 Nephrolithiasis is a common disease affecting more than 10% of the population in 
Western countries with a high recurrence rate. The annual cost in the United States was $2 
billion in 2000 and it is increasing with time [1]. The causes are diverse, including dietary 
disequilibrium, urinary tract infection and metabolic disorders related to acquired or genetic 
diseases. Although stone classifications commonly distinguish only few chemical compounds, 
namely calcium, uric acid, cystine and infection stones, physical analysis may identify a wide 
variety of components. More than 100 mineral or organic compounds have been identified to 
date [2]. In industrialized countries and in an increasing number of developing countries so-
called calcium stones account for about 90% of all urinary calculi with calcium oxalate the 
most frequent chemical species [3-5]. However, calcium stones can be divided into subgroups 
according to the main crystalline phase, which is often a strong marker of a specific urine 
composition [6]. Of the calcium phosphate stones those of carbapatite (crystallized carbonated 
hydroxyapatite) may result from urinary tract infection or metabolic factors such as 
hypercalciuria, phosphate leak or tubular acidification defects. 
 Although rare, some genetic or acquired diseases may be responsible for severe forms 
of urolithiasis associated with nephrocalcinosis and end stage renal failure, especially when 
the diagnosis is delayed. For example, in primary hyperoxaluria cases stone morphology and 
not composition could help with the diagnosis [7]. Thus, stone morphology appears to be a 
convenient, straightforward and useful examination to diagnose this rare but severe 
pathological composition while stone composition alone does not lead to the diagnosis. 
 Based on this background we hypothesized that other varieties of stones could benefit 
from morphological examination. An example would be calcium phosphate stones, which 
account for 10% to 15% of all calculi and result from urinary tract infections and/ or different 
metabolic disorders such as idiopathic hypercalciuria, hyperparathyroidism, phosphate leak, 
tubular acidosis or an excessive alkali load [8,9]. 
 The advantage of adding a stone morphology examination to infrared analysis is to 
provide a rapid, inexpensive orientation to specific pathological conditions that could not be 
readily identified when extensive metabolic investigations are not systematically performed. 
For example, in our experience the identification of typical IVa2 morphology led to the 
diagnosis of poorly symptomatic Sjögren syndrome with incomplete dRTA.  
 We sought to provide evidence that in addition to infrared spectroscopy, determining 
stone morphology is a key step in the diagnostic procedure of stone analysis that may identify 
sometimes unexpected metabolic or monogenic related stone diseases. 
 
Patients and Methods 
 
 Of 60,564 stones analysed by morphological examination and infrared spectroscopy at 
our laboratory 6,439 (10.6%) were mainly composed of calcium phosphate (more than 50% of 
the stone mass), including carbapatite, brushite, octacalcium phosphate pentahydrate, 
amorphous carbonated calcium phosphate or whitlockite. Of the stones 5,181 were mainly 
composed of carbapatite, representing 80.5% of calcium phosphate stones and 8.5% of the 
whole series. Stones containing any proportion of struvite, which more specifically indicates 
urinary tract infection with ureolytic microorganisms, were excluded from analysis. Because 
Calcium phosphate may be associated with a high proportion of calcium oxalate in a number 
of cases and, thus, be related to various metabolic conditions, we selected only stones 
containing an unambiguously high proportion of calcium phosphate, namely 70% of the 
whole stone content on infrared spectroscopy. Finally, we included in study only calculi 
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associated with a detailed etiological diagnosis provided by physicians, which was available 
for 1,093 patients. 
 Of the relevant diagnoses dRTA was diagnosed first based on low serum bicarbonate, 
moderately low arterial pH (excluding pulmonary alkalosis), low urine ammonium, urine pH 
greater than 6.5 and in some cases a bicarbonate load test. In addition, when measured, urine 
citrate was low in the absence of urinary tract infection, commonly less than 0.7 mmol per 24 
hours. The diagnosis of inherited dRTA was proven by DNA sequencing of the Cl
-
 HCO3
-
 
exchanger gene (SLC4A1) or the H
+
 adenosine triphosphatase gene (ATP6V0A4 or 
ATP6V1B1). MSK was diagnosed by computerized tomodensitometry or excretory urogram. 
Sjögren disease was diagnosed by at least 4 classic criteria, including a salivary gland biopsy 
based Chisholm score of greater than 3 and autoimmunity. 
 
Morphological Examination and Infrared Analysis 
 
 Each calculus was studied using a stereomicroscope to define morphological type and 
structural characteristics as previously described.10 This also enabled the selection of 
representative parts of the stone for infrared analysis, such as the nucleus, the inner and 
external layers, and the surface [11]. Spectra were recorded by a Spectrospin Vector 22 
Fourier transform infrared spectrometer (Bruker, Karlsruhe, Germany). Figure 1, a shows the 
½F1typical spectra of carbapatite stones. 
 
SEM and Statistics 
 
 A SUPRA 55-VP type environmental SEM (Carl Zeiss, Oberkochen, Germany) was 
used to observe the microstructure. This field effect gunmicroscope operates at 0.5 to 30 kV. 
High resolution observations were made using 2 secondary electron detectors, including an in-
lens secondary electron detector and an Everhart-Thornley secondary electron detector. An 
important feature of the environmental SEM compared to a conventional SEM is that 
nonconductive materials can be imagedwithout a conductive coating,which permits direct 
observation with no damage to the sample. The Fisher exact test was used for statistical 
comparison between groups. Statistical analysis was done with NCSS software. 
 
RESULTS 
 
 While the infrared spectra of carbapatite stones were similar, the stones showed 2 
morphological types (see Appendix and fig. 1, a to c). Stones of the first type, which was 
more common, had a homogenous rough surface and a poorly organized section of diffuse, 
whitish, concentric layers (fig. 1, b). The second type of stones showed a peculiar morphology 
characterized by a homogeneous smooth surface with a glazed appearance, bumps and cracks, 
and a heterogeneous inner organization of yellow-brown concentric foliated structures (fig. 1, 
c). In a previous morphoconstitutional classification of stones the 2 morphologies were 
termed types IVa1 and IVa2, respectively.10 The ultrastructure revealed by SEM confirmed a 
different stone pattern between the 2 morphological types (fig. 1, d and e). 
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Figure 1. a, typical FTIR spectroscopy spectra of IVa2 and IVa1 type kidney stones. b, 
external and internal optical images of IVa1 type. c, external and internal optical images of 
IVa2 type. Arrows indicate surface cracks. d, SEM image shows type IVa1. e, SEM image 
shows type IVa2. d and e, scale bar indicates 10 m. 
 
 Of the 1,093 stones containing more than 70% calcium phosphate IVa1 stones were 
more common (87.2% of cases) than IVa2 stones. They were mainly related to chronic 
urinary tract infection in 39.6% of cases, hypercalciuria in 25%, MSK in 17% and primary 
hyperparathyroidism in 9.8% (see table 1). 
 
Table 1. IVa1 and IVa2 types among mainly Ca phosphate calculi by etiology (p <0.0001). 
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 In contrast, IVa2 stones, representing only 12.8% of carbapatite stones, were associated 
with inherited dRTA in 52.9% of cases, MSK in 35% and Sjögren syndrome in 9.3%. Thus, 
the specificity of IVa2 calculi for these 3 diseases was excellent at 94.3%. The IVa2 type was 
found in 96.1% of the 77 cases of inherited dRTA diagnosed in this series vs less than 1% of 
IVa1 CA stones, representing 93.5% specificity (p <0.00001). Figure 2 shows the distribution 
½F2of carbapatite stone types by etiology. In 3 cases the peculiar IVa2 stone morphology 
prompted us to search for inherited dRTA, which was confirmed by further metabolic 
evaluation. In another 3 cases the IVa2 stone morphology led to the diagnosis of Sjögren 
syndrome. 
 
DISCUSSION 
 
 Kidney stones containing calcium phosphate are divided into 4 morphological types 
based on infrared analysis [2], including types IVa1 and IVa2-carbapatite, IVb-mixtures of 
carbapatite with other calcium or magnesium phosphates, IVc-struvite (excluded in this study) 
and IVd- brushite. A number of these stones are clearly distinguished by infrared analysis, for 
example brushite stones (IVd stones) or mixtures of various calcium and/or magnesium 
phosphates as in IVb stones. In the last 20 years we found a dramatic decrease in the 
incidence of infection stones related to urea-splitting bacteria while the proportion of IVb 
stones constantly decreased. Ambiguity remains for calcium phosphate stones mainly 
composed of carbapatite without struvite. As previously reported some of them may be 
related to urinary tract infection due to the high carbonate content found on infrared 
spectroscopy [12]. Carbapatite rich calcium phosphate stones may have 2 distinct 
morphologies (types IVa1 and IVa2) while the infrared spectra are often similar (fig. 1, a). 
We deliberately selected calculi mainly composed of carbapatite with a greater than 70% 
calcium phosphate level. 
 
Figure 2. Carbapatite stone types by IVa1 and IVa2 etiology, including 0.3% and 52.9% for 
dRTA, 17.0% and 35.0% for MSK, 0.7% and 9.3% for Sjögren syndrome, 5.2% and 1.4% for 
carbonic anhydrase inhibitors (CAI ), 9.8% and 0.0% for primary hyperparathyroidism 
(PHPT), 25.0% and 0.0% for idiopathic hypercalciuria (IH ), 39.6% and 1.4% for urinary 
tract infection (UTI ), and 2.4% and 0.0% for phosphate leak, respectively. Asterisk indicates 
p <0.001 vs IVa1. 
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 As noted in the current study IVa1 and IVa2 stones are associated with different 
pathological conditions. The main causes of IVa1 stones are those commonly reported in the 
literature for calcium phosphate stones, ie urinary tract infection, hypercalciuria and primary 
hyperparathyroidism [13-15]. In contrast, type IVa2 stones appear specific to inherited dRTA 
(see table). Interestingly IVa2 calculi are not associated with proximal tubular acidosis since 
stones in 96.2% of patients treated with carbonic anhydrase inhibitors, which induce proximal 
and distal tubular acidosis, were mainly type IVa1. Thus, IVa2 stone formation seems to 
depend on sustained high pH in the distal part of the nephron lumen, a setting present in 
dRTA due to Hþ secretion defects [16]. The typical metabolic acidosis profile may be missing 
in incomplete dRTA. Sjögren syndrome and MSK are significantly associated with high 
urinary pH related to incomplete distal acidosis, ie an acidification defect affecting only the 
distal segment of some nephrons [17-19]. In 1 series a distal acidification defect was observed 
in up to 40% of patients with MSK [20]. However, another study failed to show evidence of 
an acidification defect in a significant proportion of patients with MSK [21]. In clinical 
practice the MSK diagnosis is difficult to assess by excretory urogram as suggested by 
discrepancies in the incidence of MSK in stone forming patients in the literature (range 3.5% 
to 21%) [22-24]. These discrepancies are due to various criteria used to diagnose MSK. Until 
the recent optimization of diagnostic methods based on computerized tomography the 
identification of MSK anatomical defects was complex [25]. In our experience calcium 
oxalate (67.4%) and calcium phosphate (26.7%) were the main component of stones in 576 
patients with MSK (unpublished data). IVa2 stones were noted only in 8.2% of cases. Thus, 
MSK appears to be a heterogeneous entity. The previously demonstrated link between IVa2 
and distal acidosis suggests that IVa2 stones in patients with MSK would be the hallmark of a 
local acidification defect responsible for incomplete renal tubular acidosis. In cohorts of 
patients with Sjögren syndrome renal involvement was estimated to be between 25% and 
40%.26e28 In clinical practice it is not always easy to make the diagnosis because metabolic 
disorders may be absent or not specific, such as hypocitruria, which is a common finding in 
nephrolithiasis cases. Thus, hypocitruria is not pathognomonic for distal tubular defect 
because it is often found in patients with another condition such as urinary tract infection as 
well as in idiopathic calcium stone formers [29]. Moreover, Sjögren syndrome may be poorly 
symptomatic. In our experience identifying the typical IVa2 stone morphology led to the 
diagnosis in several cases.  
 Our series clearly shows the strong link between dRTA and IVa2. Among other 
etiologies we found a high rate of the IVa2 type in calcium phosphate stones in patients with 
Sjögren syndrome (65%) or MSK (23.2%), suggesting that patients with such a stone 
morphology have a defect of distal acidification. Thus, an early diagnosis first indicated by 
typical IVa2 stone morphology may have major clinical relevance. 
 The high prevalence of inherited or acquired dRTA in IVa2 stone group (136 patients or 
97%) may also explain why IVa2 stones are more active and recurrent than IVa1 stones. In 
our series 79.8% of patients with IVa2 stones had multiple recurrent stone episodes while the 
recurrence rate was only 54.7% in patients with IVa1 stones (p <0.0001). 
 Thus, this high risk population deserves reinforced medical management that especially 
focuses on water and alkali intake. In contrast to IVa1 stones, no primary 
hyperparathyroidism, idiopathic hypercalciuria or phosphate leak (also called type III 
hypercalciuria) was observed in IVa2 stone cases. This provides interesting clinical clues and 
evidence that a high urinary calcium rate is not associated with this specific morphological 
type. 
 Our study has limitations. 1) It was based on a declarative diagnosis by physicians who 
completed a detailed form including all relevant diagnoses, limiting the study to 1,093 
patients. 2) The MSK diagnosis is often complex. Incomplete distal tubular acidosis may be 
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under diagnosed in the absence of an acidification test. It could be interesting to assess 
whether a IVa2 stone is a feature of underlying acidosis in MSK cases, which deserves further 
study. 
 
CONCLUSIONS 
 
 To our knowledge our data address a new paradigm in stone disease and demonstrate 
the interest in stone morphology analysis in addition to composition, as recently suggested by 
Williams and McAteer [30]. For the patient it appears highly effective and beneficial to assess 
an unexpected etiology that is often responsible for recurrent calculi and/or progressive renal 
failure, or to link/exclude stone disease using metabolic or pathological findings. For the first 
time to our knowledge our study shows the strong, specific link between dRTA and 
carbapatite stone morphological type IVa2 irrespective of the cause of dRTA. Notably stone 
disease may be the most prominent sign of acquired tubular acidosis before extrarenal 
manifestations. In such cases stone morphology provides strong evidence of dRTA. 
 Thus, it allows for early diagnosis and subsequent early medical management, which 
helps prevent the progression of chronic kidney disease. In addition to infrared spectroscopy 
analysis, stone morphology appears to be a major analytical step to make an etiological 
diagnosis of calcium phosphate kidney stones, as previously illustrated for calcium oxalate 
monohydrate stones in primary hyperoxaluria cases [7]. 
 
APPENDIX 
Main morphological differences between IVa1 and IVa2 stone types. 
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